Group One Trading, L.P. Bridge Bio Pharma, Inc. Transaction History

Group One Trading, L.P.

$2.2 Billion
Q1 2025

A detailed history of Group One Trading, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 12,837 shares of BBIO stock, worth $593,454. This represents 0.02% of its overall portfolio holdings.

Number of Shares

12,837

Previous 233,137 94.49%

Holding current value

$593,454

Previous $6.4 Million 93.07%

% of portfolio

0.02%

Previous 0.24%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$28.12 - $37.59 $6.19 Million - $8.28 Million	-220,300 Reduced 94.49%	12,837 $443,000
Q4 2024 Feb 14, 2025	BUY	$22.35 - $29.5 $2.42 Million - $3.19 Million	108,235 Added 86.66%	233,137 $6.4 Million
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $2.99 Million - $3.91 Million	124,902 New	124,902 $3.18 Million
Q3 2023 Nov 09, 2023	SELL	$16.89 - $35.01 $984,534 - $2.04 Million	-58,291 Reduced 54.56%	48,540 $1.28 Million
Q2 2023 Aug 09, 2023	SELL	$13.29 - $18.01 $171,467 - $232,365	-12,902 Reduced 10.78%	106,831 $1.84 Million
Q1 2023 May 12, 2023	BUY	$7.17 - $18.55 $858,485 - $2.22 Million	119,733 New	119,733 $1.99 Million
Q2 2022 Aug 11, 2022	BUY	$5.21 - $12.14 $285,940 - $666,279	54,883 Added 189.42%	83,858 $761,000
Q1 2022 May 12, 2022	SELL	$7.34 - $17.16 $573,261 - $1.34 Million	-78,101 Reduced 72.94%	28,975 $294,000
Q4 2021 Feb 11, 2022	BUY	$11.38 - $53.41 $1.22 Million - $5.72 Million	107,076 New	107,076 $1.79 Million

Others Institutions Holding BBIO

# of Institutions

370

Shares Held

184M

Call Options Held

12.8M

Put Options Held

2.09M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $6.85B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Bridge Bio Pharma, Inc. Transaction History